Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles

Journal of Pharmacological and Toxicological Methods

Volumn 64, Issue 2, 2011, Pages 111-118

  Heerdt, Paul M ^a   Wagner, Christa L ^a   DeMais, Marissa ^b   Savarese, John J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b The Holleran Center for Community Action and Public Policy   (United States)

Author keywords

Beagle; Bioreactance; Cardiac output; Toxicology

Indexed keywords

MUSCLE RELAXANT AGENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; BIOREACTANCE; CONTROLLED STUDY; DOG; DRUG INDUCED DISEASE; DRUG MEGADOSE; HEART BEAT; HEART OUTPUT; HEART OUTPUT MEASUREMENT; HEART STROKE VOLUME; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; PHYSICAL PHENOMENA; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STEADY STATE;

ANIMALS; AORTA; CARDIAC OUTPUT; DOGS; DRUG EVALUATION, PRECLINICAL; MALE; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKING AGENTS; TIME FACTORS;

SUIDAE;

EID: 80054847610     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.03.006     Document Type: Article

References (19)

1. Belik J., Pelech A. Thoracic electric bioimpedance measurement of cardiac output in the newborn infant. Jornal de Pediatria 1988, 113:890-895.
2. Bland J.M., Altman D.G. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
3. Cecconi M., Rhodes A., Poloniecki J., Della Rocca G., Grounds R.M. Bench-to-bedside review: The importance of the precision of the reference technique in method comparison studies-with specific reference to the measurement of cardiac output. Critical Care 2009, 13:201.
4. Critchley L.A.H., Critchley J.A.J.H. A meta-analysis of studies using bias and precision statistics to compare cardiac output measurement techniques. Journal of Clinical Monitoring 1999, 15:85-91.
5. de Waal E.E., Wappler F., Buhre W.F. Cardiac output monitoring. Current Opinion in Anaesthesiology 2009, 22:71-77.
6. Dyson D.H., Sinclair M.D. Impact of dopamine or dobutamine infusions on cardiovascular variables after rapid blood loss and volume replacement during isoflurane-induced anesthesia in dogs. American Journal of Veterinary Research 2006, 67:1121-1130.
7. Heerdt P.M., Kang R., The A., Hashim M., Mook R.J., Savarese J.J. Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A in dogs. Anesthesiology 2004, 100:846-851.
8. Heerdt P.M., Malhotra J.K., Pan B., Sunaga H., Savarese J.J. Pharmacodynamics and cardiopulmonary effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs. Anesthesiology 2010, 112:910-916.
9. Introna R.P., Pruett J.K., Crumrine R.C., Cuadrado A.R. Use of transthoracic bioimpedance to determine cardiac output in pediatric patients. Critical Care Medicine 1988, 16:1101-1105.
10. Keren H., Burkhoff D., Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. American Journal of Physiology. Heart and Circulatory Physiology 2007, 293:H583-H589.
11. Lugo S.I., Liang Z., Eddington N.D. Pharmacokinetics and pharmacodynamics of mivacurium stereoisomers in beagle dogs using twitch height and train-of-four response. Biopharmaceutics & Drug Disposition 1998, 19:485-491.
12. Maurer M.M., Burkhoff D., Maybaum S., Franco V., Vittorio T.J., Williams P., White L., Kamalakkannan G., Myers J., Mancini D.M. A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. Journal of Cardiac Failure 2009, 15:689-699.
13. Nusmeier A., van der Hoeven J.G., Lemson J. Cardiac output monitoring in pediatric patients. Expert Review of Medical Devices 2010, 7:503-517.
14. Raval N.Y., Squara P., Cleman M., Yalamanchili K., Winklmaier M., Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. Journal of Clinical Monitoring and Computing 2008, 22:113-119.
15. Savarese J.J., Belmont M.R., Van Ornum S.G., Schad B., McGilvra J., Sunaga H., Savard P., Heerdt P.M. Rapid chemical antagonism of neuromuscular blockade by l-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011. Anesthesiology 2010, 113:58-73.
16. Squara P., Cecconi M., Rhodes A., Singer M., Chiche J.D. Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Medicine 2009, 35:1801-1808.
17. Squara P., Rotcajg D., Denjean D., Estagnasie P., Brusset A. Comparison of monitoring performance of Bioreactance vs. pulse contour during lung recruitment maneuvers. Critical Care 2009, 13:R125.
18. Sunaga H., Malhotra J.K., Yoon E., Savarese J.J., Heerdt P.M. Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: Pharmacodynamics and cardiovascular effects. Anesthesiology 2010, 112:900-909.
19. Yamashita K., Ueyama Y., Miyoshi K., Igarashi R., Kushiro T., Umar M.A., Muir W.W. Minimally invasive determination of cardiac output by transthoracic bioimpedance, partial carbon dioxide rebreathing, and transesophageal Doppler echocardiography in beagle dogs. The Journal of Veterinary Medical Science 2007, 69:43-47.